Q-linea AB

49
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011527845
SEK
23.07
0.75 (3.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Q-linea AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-182.00
-216.00
-229.00
-268.00
-231.00
-218.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
16.00
-18.00
2.00
-29.00
-28.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-162.00
-182.00
-228.00
-250.00
-249.00
-237.00
Cash Flow from Investing Activities
-7.00
-5.00
-7.00
315.00
-23.00
-32.00
Cash Flow from Financing Activities
402.00
131.00
245.00
-6.00
278.00
253.00
Net Cash Inflow / Outflow
232.00
-56.00
9.00
57.00
4.00
-15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Q-linea AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-182.485
5.9
-187.00
-3192.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.511
-13.7
13.00
103.73%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-162.119
0.800000000000001
-162.00
-20364.87%
Cash Flow from Investing Activities
-7.216
-5
-2.00
-44.32%
Cash Flow from Financing Activities
402.12
3.3
399.00
12085.45%
Net Cash Inflow / Outflow
232.442
-3.1
235.00
7598.13%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.35
-2.2
2.00
84.09%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 11.17% vs 20.14% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-162.12
-182.50
11.17%